Novartis CSPP100A2244

Research Title: Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema

Sponsor: Novartis

Principal Investigator: Robert Stoltz, M.D Ph.D

Description: To evaluate the efficacy of oral Aliskiren on diabetic macular edema, as measured by improvement in OCT macular thickness after 12 weeks of therapy.

Start Date: August 2009

Recruitment: Completed

Project Personnel: Leslie Marcus, CCRC

Location(s): Marietta; 114 Cherry St., Suite F, Marietta, GA 30060